Logotype for ImmunityBio Inc

ImmunityBio (IBRX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for ImmunityBio Inc

Proxy filing summary

30 Apr, 2026

Voting matters and shareholder proposals

  • Shareholders will vote on the election of nine directors, each recommended by the board for approval.

  • Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is on the agenda.

  • Proxies may vote on other business that may properly come before the Annual Meeting at their discretion.

Board of directors and corporate governance

  • The slate of director nominees includes Patrick Soon-Shiong, Cheryl L. Cohen, Richard Adcock, Michael D. Blaszyk, Wesley Clark, Linda Maxwell, Christobel Selecky, Barry J. Simon, and Bruce Wendel.

Audit committee and external auditor matters

  • Deloitte & Touche LLP is recommended for ratification as the independent auditor for the 2026 fiscal year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more